Skip to main content
Top
Published in: Journal of Neurology 11/2018

01-11-2018 | Original Communication

Quality of life in a German cohort of Parkinson’s patients assessed with three different measures

Authors: M. Balzer-Geldsetzer, J. Klotsche, R. Dodel, O. Riedel, LANDSCAPE Consortium

Published in: Journal of Neurology | Issue 11/2018

Login to get access

Abstract

Background

Parkinson’s disease (PD) is characterized by severe motor and non-motor symptoms reducing patients’ quality of life (QoL). Instruments have been well established for QoL assessments in PD, including the EuroQol (EQ-5D), the Parkinson’s disease questionnaire (PDQ-39), or rather uncommon, like the WHOQOL-100. So far, the impact of variables has been investigated for each of these measures separately in different study populations, limiting the comparability of the results. Thus, this study compared the EQ-5D, PDQ-39, and the WHOQOL-100 (with its short-form WHOQOL-BREF) in the same study population.

Methods

Seventy-five PD outpatients were assessed in a prospective study, including disease severity according to Hoehn and Yahr stage (HY) and Unified Parkinson Disease Rating Scale (UPDRS). The Geriatric Depression Scale (GDS-15) screened for depression.

Results

Decreased QoL was found with all three instruments. In multivariate models, sex and treatment complications had an impact on QoL according to all three measures, while duration of PD and HY was not associated with QoL in any of them. Depression was relevant for the WHOQOL-100/WHOQOL-BREF and the PDQ-39, but not for the EQ-5D. The total variances explained by the WHOQOL-100, WHOQOL-BREF, PDQ-39, and the EQ-5D were 0.27, 0.34, 0.70, and 0.50, respectively.

Conclusions

The associations between clinical aspects of PD and QoL vary substantially among all three measures. Importantly, depression as a frequent comorbidity in PD is underestimated by the EQ-5D, but not by the PDQ-39 and the WHOQOL-100/WHOQOL-BREF. In turn, motor impairments are underestimated by the latter and associated strongest with QoL in the EQ-5D.
Appendix
Available only for authorised users
Literature
1.
go back to reference De Rijk M, Tzourio C, Breteler M et al (1997) Prevalence of parkinsonism and Parkinson’s disease in Europe: the EUROPARKINSON collaborative study. J Neurol Neurosurg Psychiatr 62:10–15CrossRef De Rijk M, Tzourio C, Breteler M et al (1997) Prevalence of parkinsonism and Parkinson’s disease in Europe: the EUROPARKINSON collaborative study. J Neurol Neurosurg Psychiatr 62:10–15CrossRef
2.
go back to reference Bach J-P, Riedel O, Klotsche J, Spottke A, Dodel R, Wittchen H-U (2012) Impact of complications and comorbidities on treatment costs and health-related quality of life in patients with Parkinson’s disease. J Neurol Sci 314:41–47CrossRefPubMed Bach J-P, Riedel O, Klotsche J, Spottke A, Dodel R, Wittchen H-U (2012) Impact of complications and comorbidities on treatment costs and health-related quality of life in patients with Parkinson’s disease. J Neurol Sci 314:41–47CrossRefPubMed
3.
go back to reference Reuter I, Ebersbach G (2012) Efficacy of exercise in Parkinson’s Disease. Akt Neurol 39:236–247CrossRef Reuter I, Ebersbach G (2012) Efficacy of exercise in Parkinson’s Disease. Akt Neurol 39:236–247CrossRef
4.
go back to reference The WHOQOL Group (1998) The World Health Organization quality of life assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 46:1569–1585CrossRef The WHOQOL Group (1998) The World Health Organization quality of life assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 46:1569–1585CrossRef
5.
go back to reference Martinez-Martin P, Jeukens-Visser M, Lyons KE et al (2011) Health-related quality-of-life scales in Parkinson’s disease: critique and recommendations. Mov Disord 26:2371–2380CrossRefPubMed Martinez-Martin P, Jeukens-Visser M, Lyons KE et al (2011) Health-related quality-of-life scales in Parkinson’s disease: critique and recommendations. Mov Disord 26:2371–2380CrossRefPubMed
6.
go back to reference Chen FP, Chang CM, Shiu JH et al (2015) A clinical study of integrating acupuncture and western medicine in treating patients with Parkinson’s Disease. Am J Chin Med 43:407–423CrossRefPubMed Chen FP, Chang CM, Shiu JH et al (2015) A clinical study of integrating acupuncture and western medicine in treating patients with Parkinson’s Disease. Am J Chin Med 43:407–423CrossRefPubMed
7.
go back to reference Hendred SK, Foster ER (2016) Use of the World Health Organization quality of life assessment short version in mild to moderate Parkinson Disease. Arch Phys Med Rehab 97:2123–2129CrossRef Hendred SK, Foster ER (2016) Use of the World Health Organization quality of life assessment short version in mild to moderate Parkinson Disease. Arch Phys Med Rehab 97:2123–2129CrossRef
8.
go back to reference Hirayamau MS, Gobbi S, Gobbi LTB, Stella F (2008) Quality of life (QoL) in relation to disease severity in Brazilian Parkinson’s patients as measured using the WHOQOL-BREF. Arch Gerontol Geriatr 46:147–160CrossRef Hirayamau MS, Gobbi S, Gobbi LTB, Stella F (2008) Quality of life (QoL) in relation to disease severity in Brazilian Parkinson’s patients as measured using the WHOQOL-BREF. Arch Gerontol Geriatr 46:147–160CrossRef
9.
go back to reference Schestatsky P, Zanatto VC, Margis R et al (2006) Quality of life in a Brazilian sample of patients with Parkinson’s disease and their caregivers. Rev Bras Psiquiatr 28:209–211CrossRefPubMed Schestatsky P, Zanatto VC, Margis R et al (2006) Quality of life in a Brazilian sample of patients with Parkinson’s disease and their caregivers. Rev Bras Psiquiatr 28:209–211CrossRefPubMed
10.
go back to reference Valeikiene V, Ceremnych J, Alekna V, Jumulynasam A (2008) Differences in WHOQOL-100 domain scores in Parkinson’s disease and osteoarthritis. Med Sci Mon 14:CR221–CR227 Valeikiene V, Ceremnych J, Alekna V, Jumulynasam A (2008) Differences in WHOQOL-100 domain scores in Parkinson’s disease and osteoarthritis. Med Sci Mon 14:CR221–CR227
11.
go back to reference Hughes A, Daniel S, Kilford L, Lees A (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatr 55:181–184CrossRef Hughes A, Daniel S, Kilford L, Lees A (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatr 55:181–184CrossRef
12.
go back to reference Balzer-Geldsetzer M, Braga da Costa AS, Kronenbürger M (2011) Parkinson’s disease and dementia: a longitudinal study (DEMPARK). Neuroepidemiol 37:168–176CrossRef Balzer-Geldsetzer M, Braga da Costa AS, Kronenbürger M (2011) Parkinson’s disease and dementia: a longitudinal study (DEMPARK). Neuroepidemiol 37:168–176CrossRef
13.
go back to reference Hoehn M, Yahr M (1967) Parkinsonism: onset, progression and mortality. Neurol 17:427–442CrossRef Hoehn M, Yahr M (1967) Parkinsonism: onset, progression and mortality. Neurol 17:427–442CrossRef
14.
go back to reference Fahn S (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Calne D (eds) Recent developments in Parkinson’s Disease. MacMillan Healthcare Information, Florham Park, pp 153–163 Fahn S (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Calne D (eds) Recent developments in Parkinson’s Disease. MacMillan Healthcare Information, Florham Park, pp 153–163
15.
go back to reference Folstein M, Folstein S, McHugh P (1975) Mini-Mental state: a practical method for grading the mental state of patients by the clinician. J Psychiatr Res 12:189–198CrossRefPubMed Folstein M, Folstein S, McHugh P (1975) Mini-Mental state: a practical method for grading the mental state of patients by the clinician. J Psychiatr Res 12:189–198CrossRefPubMed
16.
go back to reference Kalbe E, Calabrese P, Kohn N et al (2008) Screening for cognitive deficits in Parkinson’s disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument. Parkinsonism Relat Disord 14:93–101CrossRefPubMed Kalbe E, Calabrese P, Kohn N et al (2008) Screening for cognitive deficits in Parkinson’s disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument. Parkinsonism Relat Disord 14:93–101CrossRefPubMed
17.
go back to reference Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Int Med 256:183–194CrossRef Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Int Med 256:183–194CrossRef
18.
go back to reference Emre M, Aarsland D, Brown R et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707CrossRefPubMed Emre M, Aarsland D, Brown R et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707CrossRefPubMed
19.
go back to reference Yesavage J, Brink T, Rose T et al (1983) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17:37–49CrossRef Yesavage J, Brink T, Rose T et al (1983) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17:37–49CrossRef
20.
go back to reference Schrag A, Barone P, Brown R et al (2007) Depression rating scales in Parkinson’s disease: critique and recommendations. Movement Disord 22:1077–1092CrossRefPubMed Schrag A, Barone P, Brown R et al (2007) Depression rating scales in Parkinson’s disease: critique and recommendations. Movement Disord 22:1077–1092CrossRefPubMed
21.
go back to reference Brooks R (1996) Euroqol—the current state of play. Health Pol (Amst) 37:53–72CrossRef Brooks R (1996) Euroqol—the current state of play. Health Pol (Amst) 37:53–72CrossRef
22.
go back to reference Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N (1997) The Parkinson’s disease questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score. Age Ageing 26:353–357CrossRefPubMed Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N (1997) The Parkinson’s disease questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score. Age Ageing 26:353–357CrossRefPubMed
23.
go back to reference Greiner W, Claes C, Busschbach J, von der Schulenburg J (2005) Validating the EQ-5D with time trade off for the German population. Eur J Health Econ 6:123–130 Greiner W, Claes C, Busschbach J, von der Schulenburg J (2005) Validating the EQ-5D with time trade off for the German population. Eur J Health Econ 6:123–130
24.
go back to reference Peto V, Jenkinson C, Fitzpatrick R, Greenhall R (1995) The development and validation of a short measure of functioning and well-being for individuals with Parkinson’s disease. Qual Life Res 4:241–248CrossRefPubMed Peto V, Jenkinson C, Fitzpatrick R, Greenhall R (1995) The development and validation of a short measure of functioning and well-being for individuals with Parkinson’s disease. Qual Life Res 4:241–248CrossRefPubMed
25.
go back to reference Angermeyer MC, Kilian R, Matschinger (2000) WHOQOL-100 und WHQOL-BREF. Hogrefe, Göttingen Angermeyer MC, Kilian R, Matschinger (2000) WHOQOL-100 und WHQOL-BREF. Hogrefe, Göttingen
26.
go back to reference Masthoff ED, Trompenaars FJ, Van Heck GL, Hodiamont PP, De Vries J (2005) Validation of the WHO quality of life assessment instrument (WHOQOL-100) in a population of Dutch adult psychiatric outpatients. Eur Psychiatr 20:465–473CrossRef Masthoff ED, Trompenaars FJ, Van Heck GL, Hodiamont PP, De Vries J (2005) Validation of the WHO quality of life assessment instrument (WHOQOL-100) in a population of Dutch adult psychiatric outpatients. Eur Psychiatr 20:465–473CrossRef
27.
go back to reference Klotsche J, Minden K, Thon A, Ganser G, Urban A, Horneff G (2014) Improvement in health-related quality of life for children with juvenile idiopathic arthritis after start of treatment with etanercept. Arthr Care Res 66:253–262CrossRef Klotsche J, Minden K, Thon A, Ganser G, Urban A, Horneff G (2014) Improvement in health-related quality of life for children with juvenile idiopathic arthritis after start of treatment with etanercept. Arthr Care Res 66:253–262CrossRef
28.
go back to reference Alonso J, Ferrer M, Gandek B et al (2004) Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. Qual Life Res 13:283–298CrossRefPubMed Alonso J, Ferrer M, Gandek B et al (2004) Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project. Qual Life Res 13:283–298CrossRefPubMed
29.
go back to reference da Rocha NS, Fleck MP (2019) Evaluation of quality of life in adults with chronic health conditions: the role of depressive symptoms. Rev Brasil Psiquiatr 32:119–124CrossRef da Rocha NS, Fleck MP (2019) Evaluation of quality of life in adults with chronic health conditions: the role of depressive symptoms. Rev Brasil Psiquiatr 32:119–124CrossRef
30.
go back to reference van Uem JMT, Marinus J, Canning C et al (2016) Health-related quality of life in patients with Parkinson’s disease a systematic review based on the ICF model. Neurosci Biobehav Rev 61:26–34CrossRefPubMed van Uem JMT, Marinus J, Canning C et al (2016) Health-related quality of life in patients with Parkinson’s disease a systematic review based on the ICF model. Neurosci Biobehav Rev 61:26–34CrossRefPubMed
31.
go back to reference Lucas-Carrasco R, Pascual-Sedano B, Galan I, Kulisevsky J, Sastre-Garriga J, Gomez-Benito J (2011) Using the WHOQOL-DIS to measure quality of life in persons with physical disabilities caused by neurodegenerative disorders. Neurodegen Dis 8:178–186CrossRef Lucas-Carrasco R, Pascual-Sedano B, Galan I, Kulisevsky J, Sastre-Garriga J, Gomez-Benito J (2011) Using the WHOQOL-DIS to measure quality of life in persons with physical disabilities caused by neurodegenerative disorders. Neurodegen Dis 8:178–186CrossRef
32.
go back to reference König H, Bernert S, Angermeyer M (2005) Health status of the German population: results of a representative survey using the EuroQol questionnaire. Gesundheitswesen 67:173–182CrossRefPubMed König H, Bernert S, Angermeyer M (2005) Health status of the German population: results of a representative survey using the EuroQol questionnaire. Gesundheitswesen 67:173–182CrossRefPubMed
33.
go back to reference Schrag A, Jahanshahi M, Quinn N (2000) How does Parkinson’s disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 15:1112–1118CrossRefPubMed Schrag A, Jahanshahi M, Quinn N (2000) How does Parkinson’s disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 15:1112–1118CrossRefPubMed
35.
go back to reference Bettecken K, Bernhard F, Sartor J et al (2017) No relevant association of kinematic gait parameters with health-related quality of life in Parkinson’s disease. Plos One 12:e0176816CrossRefPubMedPubMedCentral Bettecken K, Bernhard F, Sartor J et al (2017) No relevant association of kinematic gait parameters with health-related quality of life in Parkinson’s disease. Plos One 12:e0176816CrossRefPubMedPubMedCentral
36.
go back to reference Lindgren HIV, Qvarfordt P, Bergman S, Gottsater A, Swedish Endovasc Claudication S (2018) Primary stenting of the superficial femoral Artery in patients with intermittent claudication has durable effects on health-related quality of life at 24 months: results of a randomized controlled trial. Cardiovasc Intervent Radiol 41:872–881CrossRefPubMedPubMedCentral Lindgren HIV, Qvarfordt P, Bergman S, Gottsater A, Swedish Endovasc Claudication S (2018) Primary stenting of the superficial femoral Artery in patients with intermittent claudication has durable effects on health-related quality of life at 24 months: results of a randomized controlled trial. Cardiovasc Intervent Radiol 41:872–881CrossRefPubMedPubMedCentral
37.
go back to reference Den Oudsten BL, Van Heck GL, De Vries J (2007) The suitability of patient-based measures in the field of Parkinson’s disease: a systematic review. Mov Disord 22:1390–1401CrossRefPubMed Den Oudsten BL, Van Heck GL, De Vries J (2007) The suitability of patient-based measures in the field of Parkinson’s disease: a systematic review. Mov Disord 22:1390–1401CrossRefPubMed
Metadata
Title
Quality of life in a German cohort of Parkinson’s patients assessed with three different measures
Authors
M. Balzer-Geldsetzer
J. Klotsche
R. Dodel
O. Riedel
LANDSCAPE Consortium
Publication date
01-11-2018
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 11/2018
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-018-9047-9

Other articles of this Issue 11/2018

Journal of Neurology 11/2018 Go to the issue